242
Participants
Start Date
August 28, 2019
Primary Completion Date
December 23, 2023
Study Completion Date
December 23, 2023
NL003
Day 0: 8mg of NL003 (32 injections of 0.5ml of NL003) Day 14: 8mg of NL003 (32 injections of 0.5ml of NL003) Day 28: 8mg of NL003 (32 injections of 0.5ml of NL003)
Normal Saline
Day 0: 16ml of Normal Saline (32 injections ) Day 14: 16ml of Normal Saline (32 injections ) Day 28: 16ml of Normal Saline (32 injections )
Peking Union Medical College Hospital, Beijing
Xuzhou Mining Group General Hospital, Xuzhou
The Affiliated Hospital of Qingdao University, Qingdao
Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou
The Second Xiangya Hospital of Central South University, Changsha
The Third Xiangya Hospital of Central South University, Changsha
First Affiliated Hospital of Xi 'an Jiaotong University, XiAn
Second Affiliated Hospital of Chongqing Medical University, Chongqing
Zhongshan Hospital Xiamen University, Xiamen
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
The First Affiliated Hospital of Zhengzhou University, Changchun
Affiliated Hospital of Inner Mongolia Medical University, Baotou
Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan
Qingdao Hiser Hospital Affiliated of Qingdao University(Qingdao Traditional Chinese Medicine Hospital), Qingdao
Fudan University Affiliated Pudong Medical Center, Shanghai
Shanghai 9th People's Hospital Affiliated to Shanghai JiaoTong University, School of Medicine;, Shanghai
The First Affiliated Hospital,Zhejiang University School of Medicine, Hangzhou
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
zhongshan Hospital Affiliated of Dalian University, Dalian
Chifeng Municipal Hospital, Chifeng
Shanxi Provincial People's Hospital, Taiyuan
Beijing Northland Biotech. Co., Ltd.
INDUSTRY